HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical significance of the interaction between lithium and a neuromuscular blocker.

Abstract
Reports of delayed recovery from anesthesia by patients concurrently receiving lithium carbonate and a neuromuscular blocker have been followed by a recommendation to avoid such a combination and, hence, concurrent treatment with lithium and electroconvulsive therapy (ECT). The authors review the literature and their clinical experience with such a drug combination at one psychiatric hospital. They conclude that the clinical and experimental findings to date are insufficient to warrant proscribing the combination of lithium and ECT on the basis of possible potentiation of neuromuscular blockade by lithium.
AuthorsB A Martin, P M Kramer
JournalThe American journal of psychiatry (Am J Psychiatry) Vol. 139 Issue 10 Pg. 1326-8 (Oct 1982) ISSN: 0002-953X [Print] United States
PMID6812439 (Publication Type: Journal Article)
Chemical References
  • Lithium Carbonate
  • Lithium
  • Succinylcholine
  • Thiopental
Topics
  • Adult
  • Aged
  • Drug Synergism
  • Electroconvulsive Therapy
  • Female
  • Humans
  • Lithium (pharmacology)
  • Lithium Carbonate
  • Male
  • Middle Aged
  • Mood Disorders (drug therapy, therapy)
  • Succinylcholine (pharmacology)
  • Thiopental

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: